We use cookies to ensure our website works properly and to personalise your experience. Cookies policy
The Tamilnadu Dr.M.G.R. medical University chennai.
Oil, water, surfactants, and co-surfactants combine to form nanoemulsions, which are colloidal systems with droplet sizes ranging from 20 to 200 nm. Nanoemulsions have become a viable carrier for atherdvanced drug delivery applications because of their small droplet size, large surface area, and improved physicochemical features. They increase the bioavailability and therapeutic efficacy of medications that are poorly soluble in water by improving their solubility and dissolution. The encapsulation of active pharmaceutical substances in nanoemulsion systems enhances stability, allows for controlled and targeted drug release, and shields medications from environmental deterioration. Surfactants are essential for maintaining the stability of nanoemulsions and affecting the properties of drug release. The use of nanoemulsions in oral, topical, ophthalmic, nasal, and parenteral drug delivery systems has increased due to developments in nanotechnology. Careful formulation design is required since variables including droplet size, surfactant content, temperature, and storage conditions affect the stability of nanoemulsi nanomedicine.
Nanoemulsion:
Oil, water, surfactants, and frequently co-surfactants make up nanoemulsions, which are nanoscale colloidal dispersions. Typically, the droplet diameters fall between 20 and 200 nm. [1, 2]. When compared to conventional emulsions, nanoemulsions have better absorption properties, better drug solubilization, and increased physical stability due to their small droplet size and wide interfacial surface area. [3]. They can be created using low-energy approaches based on phase inversion principles or high-energy procedures like high-pressure homogenization and ultrasonication [4]. Because they improve the administration of poorly water-soluble medications and increase therapeutic efficacy, nanoemulsions are extensively studied in pharmaceutical applications [5]. The nanoscale droplets speed up the breakdown of lipophilic substances and improve their ability to pass through biological membranes [6]. Oral topical, ocular, nasal, and parenteral delivery are all appropriate uses for nanoemulsions. [7]. Additionally, they can be altered for specific delivery applications and shield encapsulated medications from environmental deterioration [8]. Nanoemulsions are a promising platform for enhanced drug delivery systems and nanomedicine because of their adaptability and simplicity of formulation [9].
Drug Delivery:
Transporting medicinal substances to the intended site of action while preserving effective medication concentrations and reducing side effects is the goal of drug delivery systems [10]. Reduced therapeutic efficacy is often the result of conventional dose forms' poor absorption quick elimination and non-specific distribution [11]. To get around these restrictions, advanced drug
delivery techniques include carriers like liposomes, nanoparticles, nanoemulsions, and polymeric systems [12]. Nano-based delivery systems enhance drug solubility, shield active chemicals from deterioration, and enable regulated or targeted release [13]. By focusing medications on certain tissues or cells while lowering systemic toxicity, targeted drug delivery improves therapy efficacy [14]. Because selective accumulation of anticancer medications might enhance clinical results, these systems are especially useful in cancer therapy [15]. The goal of current drug delivery research is to create stimuli-responsive carriers that can release medications in reaction to external signals, pH, temperature, or enzymes [16]. These developments have greatly increased patient compliance and treatment success while also increasing the therapeutic potential of several pharmacological substances [17].
Encapsulation:
To increase stability, bioavailability, and therapeutic efficacy, active medicinal compounds are encapsulated within a protective carrier matrix [18]. Polymers, lipids, proteins, or surfactants are used in encapsulation methods to create microcapsules or nanocapsules that enclose and shield the active ingredient [19]. This method protects medications from environmental deterioration brought on by light, moisture, oxidation, and enzymatic activity [20]. Additionally, encapsulation enables therapeutic substances to be released under regulated conditions, preserving effective medication concentrations for prolonged periods of time [21]. Numerous encapsulation methods, including coacervation, spray drying, nanoprecipitation, solvent evaporation, and emulsification, are used based on the drug's physicochemical characteristics [22]. Encapsulation enhances the administration of poorly soluble medications, proteins, peptides, and nucleic acids in nanomedicine [23]. By lowering the frequency of doses and decreasing side effects, encapsulated systems can improve patient compliance [24]. Multifunctional nanocarriers with stimulus-responsive medication release and tailored delivery are the subject of recent developments [25]. As a result, encapsulation is now a crucial tactic in the creation of pharmaceutical formulations and contemporary therapeutic applications [26].
Bioavailability:
The velocity and degree to which a medication enters the bloodstream and becomes accessible at its location of action is known as bioavailability [27]. It is among the most significant factors influencing how well pharmaceutical goods work therapeutically [28]. Due to low aqueous solubility, restricted permeability, gastrointestinal tract instability, or substantial first-pass metabolism, many medications have poor bioavailability [29]. Researchers have created sophisticated formulation techniques, such as solid dispersions, lipid-based drug delivery systems, nanoemulsions, and nanoparticles, to solve these issues [30]. By accelerating the dissolution and absorption of medications that are poorly soluble in water, nanoemulsions increase bioavailability [31]. Their enormous surface area from nanoscale droplets allows for quick contact with cellular membranes and improves drug delivery [32]. Lower dosages, less toxicity, and improved therapeutic results are frequently the results of increased bioavailability [33]. Nanotechnology
developments continue to produce innovative approaches for overcoming biological barriers and maximizing drug absorption [34]. Therefore, enhancing bioavailability remains a major objective in pharmaceutical research and drug development [35].
Surfactants:
Surfactants are amphiphilic compounds that lower interfacial tension between immiscible phases, such as water and oil, by combining hydrophilic and lipophilic groups [36]. By promoting droplet formation and inhibiting coalescence, they are essential to the creation and stabilization of nanoemulsions [37]. Anionic, cationic, nonionic, and zwitterionic surfactants are categorized according to their ionic characteristics [38]. Because of their superior emulsifying qualities and low toxicity, nonionic surfactants like Tween 80 and Span 80 are frequently employed in pharmaceutical formulations [39]. By increasing their dispersion within biological fluids, surfactants increase the solubility and permeability of medications that are poorly soluble in water [40]. Additionally, they affect important formulation properties such as physical stability, drug release profile, zeta potential, and particle size [41]. The hydrophilic-lipophilic balance (HLB) value, compatibility with formulation ingredients, and planned mode of administration are frequently considered when choosing suitable surfactants [42]. Despite their advantages, high surfactant concentrations can be hazardous or irritating; therefore, formulation development must be carefully optimized [43]. Surfactants are therefore still essential parts of drug delivery systems based on nanoemulsions [44].
Nanotechnology:
In nanotechnology, materials with dimensions usually ranging from 1 to 100 nm are created, described, and used [45]. By enabling the development of nanoscale carriers that can boost therapeutic efficacy and reduce side effects, nanotechnology has revolutionized drug delivery in pharmaceutical sciences [46]. Nanocarriers such as liposomes, polymeric micelles, nanoparticles, nanoemulsions, and dendrimers enhance drug solubility, stability, and bioavailability [47]. Their small size enables improved penetration across biological barriers and targeted delivery to diseased areas [48]. Nanotechnology has shown remarkable efficacy in cancer treatment, gene delivery, vaccine development, antibiotic treatment, and diagnostic imaging [49]. By adding ligands, antibodies, or polymers to the surface of nanocarriers, targeting efficacy is further increased and circulation time is prolonged [50]. Recent advances have focused on theranostics, or multifunctional nanosystems that can simultaneously diagnose and treat patients [51]. Despite persistent concerns regarding toxicity and regulatory approval, continued research has significantly improved the safety and efficacy of nanomedicine [52]. Nanotechnology is therefore one of the most promising fields of modern pharmacological research and healthcare innovation [53].
Stability:
Stability is a critical factor in determining the efficacy, safety, and quality of a pharmaceutical formulation throughout its shelf life [54]. Despite the fact that they can experience Nanoemulsions are frequently kinetically stable systems despite instability processes such flocculation, coalescence, creaming, sedimentation, phase separation, and Ostwald ripening [55]. By altering the droplet size distribution, these instability processes may have a detrimental effect on the efficacy of treatment [56]. The stability of nanoemulsions is influenced by a number of variables, including temperature, pH, ionic strength, surfactant concentration, oil content, and storage conditions [57]. Careful formulation design and surfactant system optimization are necessary to maintain long-term stability [58]. Analytical techniques such as dynamic light scattering, zeta potential measurement, transmission electron microscopy, and accelerated stability testing are commonly employed to evaluate formulation robustness [59]. Stabilizing agents, antioxidants, and preservatives can be added to improve chemical and physical stability [60]. Regulatory agencies require comprehensive stability studies to ensure product quality and consistency during storage and transportation [61]. Stability evaluation is therefore still essential to the development and promotion of pharmaceutical products [62].
Controlled Release:
In order to keep medication concentrations within the therapeutic window, controlled-release drug delivery systems are made to release therapeutic agents at predefined rates over prolonged periods of time [63]. Controlled-release systems, in contrast to traditional dose forms, lower the frequency of delivery and lessen variations in plasma drug levels [64]. As controlled-release carriers, nanoemulsions, nanoparticles, liposomes, hydrogels, and polymeric matrices have all been thoroughly studied [65]. Diffusion, erosion, swelling, or degradation mechanisms can be used to modify drug release in these systems [66]. Formulations with controlled release increase therapeutic efficacy, decrease adverse effects, and improve patient compliance [67]. Because nanotechnology allows for fine control over particle properties and release kinetics, controlled-release techniques have been further extended [68]. An important development in this area is the development of stimuli-responsive delivery systems that can react to pH, temperature, enzymes, light, or magnetic fields [69]. These intelligent technologies reduce systemic exposure and offer site-specific medication release [70]. As a result, controlled-release technologies are still essential for developing next-generation pharmaceutical formulations and treating chronic illnesses [71].
Pharmaceutical Applications:
Because nanoemulsions can improve medication solubility, stability, permeability, and bioavailability, they have become widely used in pharmaceutical applications [72]. They are employed in oral formulations to boost therapeutic efficacy and enhance the absorption of medications that are poorly soluble in water [73]. Topical and transdermal nanoemulsions minimize systemic negative effects while improving skin penetration and localized medication delivery [74]. Nanoemulsions enhance corneal penetration and extend residence duration in ocular medication delivery [75]. Lipophilic medications and dietary supplements are administeredintravenously using parenteral nanoemulsions [76]. Furthermore, nanoemulsions have shown great promise in gene delivery, antibiotic treatment, cancer therapy, and vaccine administration [77]. Their tiny droplets allow for tailored drug administration and effective transport across cellular membranes [78]. Nanoemulsion technologies are being used more and more by the pharmaceutical industry to create novel medicines with enhanced therapeutic effectiveness [79]. It is anticipated that ongoing developments in formulation science and nanotechnology will increase the therapeutic uses of nanoemulsions and position them as adaptable platforms for upcoming drug delivery systems [80].
REFERENCES
Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions. Curr Opin Colloid Interface Sci. 2005;10:102–110.
Adv Drug Deliv Rev. 2012;64:206–212.
Nanomaterials. 2019;9:1357.
Chem Rev. 2016;116:2602–2663.
Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions. Curr Opin Colloid Interface Sci. 2005;10:102–110.
Adv Drug Deliv Rev. 2012;64:206–212.
Nanomaterials. 2019;9:1357.
Chem Rev. 2016;116:2602–2663.
Anton. D. Divine, Christopher Vimalson, Alagarraja, Aathi Varman, Dharun Kumar, Gayathiri, Harish, Sethupathi, Nanoemulsion-Based Drug Delivery Systems: Definition, Encapsulation, Bioavailability, Stability, Controlled Release and Pharmaceutical Applications, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 7, 3813-3820, https://doi.org/10.5281/zenodo.21450690
10.5281/zenodo.21450690